Patents by Inventor Martin Kjell Lindberg

Martin Kjell Lindberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5976861
    Abstract: Method for producing a protein having the same IgG specificity as protein G from group G Streptococci, strain G148. The invention also relates to a recombinant DNA molecule coding for said protein, and to microorganisms containing this recombinant DNA molecule. The invention also relates to a recombinant DNA molecule coding for a protein having the IgG binding specificity of both protein G and protein A.
    Type: Grant
    Filed: May 16, 1989
    Date of Patent: November 2, 1999
    Assignee: Pharmacia Biotech Aktiebolag
    Inventors: Bengt Mikael Guss, Jan Ingmar Flock, Martin Kjell Lindberg, Mathias Carl Erik Uhlen
  • Patent number: 5770702
    Abstract: The present invention relates to a new recombinant hybrid-DNA-molecule comprising a nucleotide sequence from S. aureus coding for a protein, or polypeptide, having fibronectin binding properties.
    Type: Grant
    Filed: October 7, 1996
    Date of Patent: June 23, 1998
    Inventors: Magnus Hook, Martin Kjell Lindberg, Lars Christer Signas, Torkel Mikael Wadstrom, Gunnar Froman
  • Patent number: 5756670
    Abstract: Method for producing a protein having the same IgG specificity as protein G from group G Streptococci, strain G148. The invention also relates to a recombinant DNA molecule coding for said protein, and to microorganisms containing this recombinant DNA molecule. The invention also relates to a recombinant DNA molecule coding for a protein having the IgG binding specificity of both protein G and protein A.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 26, 1998
    Assignee: Pharmacia Biotech Aktiebolag
    Inventors: Bengt Mikael Guss, Jan Ingmar Flock, Martin Kjell Lindberg, Mathias Carl Erik Uhlen